Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
- PMID: 17514749
- PMCID: PMC2836920
- DOI: 10.1002/ana.21157
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
Abstract
Objective: An inversion polymorphism of approximately 900 kb on chromosome 17q21, which includes the microtubule-associated protein tau (MAPT) gene defines two haplotype clades, H1 and H2. Several small case-control studies have observed a marginally significant excess of the H1/H1 diplotype among patients with Parkinson's disease (PD), and one reported refining the association to a region spanning exons 1 to 4 of MAPT. We sought to replicate these findings.
Methods: We genotyped 1,762 PD patients and 2,010 control subjects for a single nucleotide polymorphism (SNP) that differentiates the H1 and H2 clades. We also analyzed four SNPs that define subhaplotypes within H1 previously reported to associate with PD or other neurodegenerative disorders.
Results: After adjusting for age, sex, and site, we observed a robust association between the H1/H1 diplotype and PD risk (odds ratio for H1/H1 vs H1/H2 and H2/H2, 1.46; 95% confidence interval, 1.25-1.69; p = 8 x 10(-7)). The effect was evident in both familial and sporadic subgroups, men and women, and early- and late-onset disease. Within H1/H1 individuals, there was no significant difference between cases and control subjects in the overall frequency distribution of H1 subhaplotypes.
Interpretation: Our data provide strong evidence that the H1 clade, which contains MAPT and several other genes, is a risk factor for PD. However, attributing this finding to variants within a specific region of MAPT is premature. Thorough fine-mapping of the H1 clade in large numbers of individuals is now needed to identify the underlying functional variant(s) that alter susceptibility for PD.
Figures

Similar articles
-
Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.Eur J Hum Genet. 2007 Nov;15(11):1163-8. doi: 10.1038/sj.ejhg.5201901. Epub 2007 Jul 18. Eur J Hum Genet. 2007. PMID: 17637803
-
H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.Neurosci Lett. 2019 Jan 18;690:210-213. doi: 10.1016/j.neulet.2018.10.029. Epub 2018 Oct 16. Neurosci Lett. 2019. PMID: 30339920
-
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.Neurobiol Aging. 2009 Sep;30(9):1477-82. doi: 10.1016/j.neurobiolaging.2007.11.019. Epub 2007 Dec 26. Neurobiol Aging. 2009. PMID: 18162161
-
Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.Neurobiol Dis. 2007 Jul;27(1):1-10. doi: 10.1016/j.nbd.2007.04.006. Epub 2007 May 5. Neurobiol Dis. 2007. PMID: 17555970 Free PMC article. Review.
-
Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.Oncotarget. 2017 Jul 4;8(27):44994-45007. doi: 10.18632/oncotarget.16690. Oncotarget. 2017. PMID: 28402959 Free PMC article. Review.
Cited by
-
APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.J Parkinsons Dis. 2016 Apr 2;6(2):349-59. doi: 10.3233/JPD-150762. J Parkinsons Dis. 2016. PMID: 27061069 Free PMC article.
-
Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients.J Neural Transm (Vienna). 2011 Jun;118(6):889-97. doi: 10.1007/s00702-011-0591-z. Epub 2011 Feb 23. J Neural Transm (Vienna). 2011. PMID: 21344240
-
Tau: a biomarker of Huntington's disease.Mol Psychiatry. 2023 Oct;28(10):4070-4083. doi: 10.1038/s41380-023-02230-9. Epub 2023 Sep 25. Mol Psychiatry. 2023. PMID: 37749233 Review.
-
Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.J Neurol. 2024 Jun;271(6):2992-3018. doi: 10.1007/s00415-024-12314-3. Epub 2024 Mar 30. J Neurol. 2024. PMID: 38554150 Free PMC article. Review.
-
A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies.Curr Protein Pept Sci. 2018;19(6):598-611. doi: 10.2174/1389203718666171117110028. Curr Protein Pept Sci. 2018. PMID: 29150919 Free PMC article. Review.
References
-
- Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121–1159. - PubMed
-
- Pittman AM, Fung HC, de Silva R. Untangling the tau gene association with neurodegenerative disorders. Hum Mol Genet. 2006;15 suppl 2:R188–R195. - PubMed
-
- Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8:711–715. - PubMed
-
- Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001;56:1702–1706. - PubMed
-
- Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702–705. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases